Based on data from the past 90 days ending December 12, 2025, Camp4 Therapeutics's three largest insider shareholders are TenPercentOwner Sciences Gp, Llc Enavate (3.79Mn shares), Director Andrew J. Schwab (2.94Mn shares), TenPercentOwner Partners Vi, Llc 5Am (2.94Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Sciences Gp, Llc Enavate | 3,785,802 | 17 Oct, 2024 | |
| Partners Vi, Llc 5Am | 2,941,176 | 15 Sep, 2025 | |
| Andrew J. Schwab | 2,941,176 | 15 Sep, 2025 | |
| Ventures Ii Gp, Llc Northpond | 763,636 | 17 Oct, 2024 | |
| Equity Partners Bio I, L.L.C. Ah | 545,454 | 17 Oct, 2024 | |
| Josh Mandel-Brehm | Chief Executive Officer | 278,417 | 11 Sep, 2025 |
| Amir Nashat | 197,661 | 11 Sep, 2025 | |
| Management Co. Vii, L.L.C. Polaris | 197,661 | 11 Sep, 2025 | |
| Richard A Young | 170,010 | 11 Sep, 2025 | |
| Steven H Holtzman | 108,946 | 15 Oct, 2024 | |
| Kelly Gold | Chief Financial Officer | 67,877 | 11 Sep, 2025 |
| Yuri Maricich | Chief Medical Officer | 6,060 | 11 Sep, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Sep, 2025 | Kelly Gold | Common Stock | A | 6,060 | $1.65 | 67,877 | D | P |
| 11 Sep, 2025 | Andrew J. Schwab | Common Stock | A | 2,941,176 | $1.53 | 2,941,176 | I | A |
| 11 Sep, 2025 | Josh Mandel-Brehm | Common Stock | A | 6,060 | $1.65 | 278,417 | D | P |
| 11 Sep, 2025 | Amir Nashat | Common Stock | A | 1,221,721 | $1.53 | 2,825,500 | I | P |
| 11 Sep, 2025 | Richard A Young | Common Stock | A | 15,151 | $1.65 | 170,010 | D | P |
| 11 Sep, 2025 | Management Co. Vii, L.L.C. Polaris | Common Stock | A | 1,221,721 | $1.53 | 2,825,500 | I | P |
| 11 Sep, 2025 | Yuri Maricich | Common Stock | A | 6,060 | $1.65 | 6,060 | D | P |
| 11 Sep, 2025 | Partners Vi, Llc 5Am | Common Stock | A | 2,941,176 | $1.53 | 2,941,176 | I | P |
| 11 Sep, 2025 | Amir Nashat | Common Stock | A | 85,468 | $1.53 | 197,661 | I | P |
| 11 Sep, 2025 | Management Co. Vii, L.L.C. Polaris | Common Stock | A | 85,468 | $1.53 | 197,661 | I | P |
| 15 Oct, 2024 | Andrew J. Schwab | Common Stock | A | 1,337,592 | - | 1,337,592 | I | C |
| 15 Oct, 2024 | Steven H Holtzman | Common Stock | A | 8,917 | - | 108,946 | D | C |
| 15 Oct, 2024 | Richard A Young | Common Stock | A | 8,917 | - | 154,859 | D | C |
| 15 Oct, 2024 | Ventures Ii Gp, Llc Northpond | Common Stock | A | 1,003,193 | - | 1,003,193 | I | C |
| 15 Oct, 2024 | Sciences Gp, Llc Enavate | Common Stock | A | 2,422,166 | - | 2,422,166 | I | C |
| 15 Oct, 2024 | Josh Mandel-Brehm | Common Stock | A | 605 | - | 272,357 | D | C |
| 15 Oct, 2024 | Amir Nashat | Common Stock | A | 1,250,061 | - | 1,250,061 | I | C |
| 15 Oct, 2024 | Management Co. Vii, L.L.C. Polaris | Common Stock | A | 1,250,061 | - | 1,250,061 | I | C |
| 15 Oct, 2024 | Partners Vi, Llc 5Am | Common Stock | A | 1,716,055 | - | 1,716,055 | I | C |
| 15 Oct, 2024 | Equity Partners Bio I, L.L.C. Ah | Common Stock | A | 1,398,067 | - | 1,398,067 | I | C |